| Home > Authorities > Institutes > Record #170070 |
W630
Radiopharmazeutika und Präklinische Studien| ID | I:(DE-He78)W630-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study.
BMC cancer 26(1), 1038 (2026) [10.1186/s12885-026-16791-9]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Differential Radiobiological Effects of Αlpha- and Beta-Minus-Emitter Targeted Radionuclide Therapy: DNA Damage and Survival.
International journal of radiation oncology, biology, physics nn, nn (2026) [10.1016/j.ijrobp.2026.08.036]
BibTeX |
EndNote:
XML,
Text |
RIS
Preprint
Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225 Ac]Ac-/[177 Lu]Lu-PSMA-617 therapy for metastatic castration- resistant prostate cancer: a prospective observational study
[doi.org/10.21203/rs.3.rs-9737806/v1]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
A unified single-cell atlas of HNSCC: Toward characterizing HPV- and sex-associated TME variability
iScience 29(6), 115863 (2026) [10.1016/j.isci.2026.115863]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
High-energy resolution X-ray spectroscopy reveals bonding characteristics of La3+ homologues of actinium radiopharmaceuticals.
Communications chemistry 9, 148 (2026) [10.1038/s42004-026-01929-4]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer.
Molecular pharmaceutics 23(4), 2720-2734 (2026) [10.1021/acs.molpharmaceut.5c01853]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
EpCAM-PSMA: Potential predictors of treatment outcomes for PSMA-targeted alpha therapies in metastatic castration-resistant prostate cancer.
Molecular therapy. Oncology. 34(1), 201143 (2026) [10.1016/j.omton.2026.201143]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Genomic analysis in chemotherapy-naïve prostate cancer prior to PSMA-targeted treatment.
Frontiers in oncology 16, 1741080 (2026) [10.3389/fonc.2026.1741080]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Exploratory case series of circulating tumor DNA dynamics during tandem therapy in metastatic castration-resistant prostate cancer
EJNMMI Research 16(1), 43 (2026) [10.1186/s13550-026-01388-x]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience.
Theranostics 16(14), 7926 - 7936 (2026) [10.7150/thno.129889]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |